Dna Group (T.R.) Balance Sheet Health
Financial Health criteria checks 6/6
Dna Group (T.R.) has a total shareholder equity of ₪98.3M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪99.6M and ₪1.3M respectively.
Key information
0%
Debt to equity ratio
₪0
Debt
| Interest coverage ratio | n/a |
| Cash | ₪67.33m |
| Equity | ₪98.30m |
| Total liabilities | ₪1.30m |
| Total assets | ₪99.60m |
Recent financial health updates
We Think Dna Group (T.R.) (TLV:DNA) Can Afford To Drive Business Growth
Apr 12
Dna Group (T.R.) (TLV:DNA) Is In A Strong Position To Grow Its Business
Jul 07We Think Dna Group (T.R.) (TLV:DNA) Can Easily Afford To Drive Business Growth
Jan 24We're Not Worried About D.N.A Biomedical Solutions' (TLV:DNA) Cash Burn
Oct 07Recent updates
Dna Group (T.R.)'s (TLV:DNA) Earnings Might Not Be As Promising As They Seem
Sep 02We Think Dna Group (T.R.) (TLV:DNA) Can Afford To Drive Business Growth
Apr 12Dna Group (T.R.) (TLV:DNA) Is In A Strong Position To Grow Its Business
Jul 07We Think Dna Group (T.R.) (TLV:DNA) Can Easily Afford To Drive Business Growth
Jan 24We're Not Worried About D.N.A Biomedical Solutions' (TLV:DNA) Cash Burn
Oct 07Financial Position Analysis
Short Term Liabilities: DNA's short term assets (₪67.5M) exceed its short term liabilities (₪666.0K).
Long Term Liabilities: DNA's short term assets (₪67.5M) exceed its long term liabilities (₪634.0K).
Debt to Equity History and Analysis
Debt Level: DNA is debt free.
Reducing Debt: DNA had no debt 5 years ago.
Debt Coverage: DNA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DNA has no debt, therefore coverage of interest payments is not a concern.